Currently, the best peripheral biomarker to discriminate PSP from PD is the neurofilament light chain (Nf-L), an axonal protein that is typically higher in PSP than in PD patients [28,29] and has been proven to be particularly effective as diagnostic biomarker when combined with MRI measurements [30,31]. Here, NEFL is linked to supranuclear palsy, progressive, 1.